Diplomat to dispense Darzalex

FLINT, Mich. — Diplomat Pharmacy will be dispensing Janssen’s Darzalex, the company announced Thursday. The drug will be dispensed in combination with Revlimid (lenalidomide) and dexamethasone or with Velcade (bortezomib) and dexamethasone. 

 

The drug was approved by the Food and Drug Administration to treat multiple myeloma in patients who have received at least one other treatment. 

 

“At Diplomat, we are focused on providing excellent care to every single patient,” Diplomat president Paul Urick said. “With Darzalex, we are able to offer a treatment to our multiple myeloma patients who have tried at least one other therapy. Along the way, our oncology team of pharmacists, nurses, and care coordinators works hard to provide a consistent high level of care to support them at all times as they grapple with multiple myeloma.”